Home |  Contact Us | Careers

 
 

• 

PDCI Market Access Services
 


 
 

Canadian Market Access Services

Reimbursement Strategies | Formulary Submissions | Budget Impact Analyses
Price Increase Strategies | Communications Plans | Seminars & Workshops


Reimbursement Strategies for Canada

For most drug products sold in Canada, reimbursement is essential for maximizing market share and revenues. Reimbursement strategies are typically developed several years before launch and are part of an integrated process that assesses the reimbursement opportunity, develops a strategy and timetable for creating awareness of the new therapy and its value and integrates the key messages into the communications and marketing plans. The objective is to develop and implement a reimbursement strategy that creates a positive reimbursement environment and clear value message.

PDCI Market Access works with clients to:

  • Develop and implement reimbursement strategies

  • Integrate the reimbursement process into the marketing and communication plans

  • Negotiate listings and listing agreements with drug plan managers

  • Maximize the reimbursement opportunity

    • Gain and improve access / achieve listings

    • Defend access (from de-listing, restrictions)

  • Facilitate and coordinate the reimbursement submission process

Formulary Submissions

With ten provincial drug plans, several federal plans and a myriad of private drug plans, understanding the unique requirements of each plan and developing effective strategies for formulary access is a complex and time consuming process. PDCI Market Access can plan and coordinate this process for you. Our excellent knowledge and understanding of the industry and extensive expertise in all aspects of product reimbursement submissions and regulations results in effective reimbursement submissions, targeting Public Payers, Private Payers (including NIHB, Veterans Affairs, etc.), Centres for Excellence for all HIV/AIDS related products, Hospitals and Cancer Centres.

PDCI Market Access develops reimbursement submissions for:

  • New Chemical Entities

  • New Indications, New Dosage Forms and Strengths

  • Re-Submissions

  • Manufacturing Changes, DIN Changes and Product Discontinuations

Budget Impact Analyses

  • PDCI Market Access provides budget impact analyses for reimbursement submissions for the public and private drug plans.

Price Increase Strategies for Formulary Drugs

Communications Plans/Advisory Boards

Training / Seminars / Workshop

  • PDCI Market Access offers client-tailored on-site seminars & workshops that allow the client to develop a clear understanding of accessing the Canadian pharmaceutical market.

For further information on formulary access strategies and reimbursement submission services please contact Neil Palmer.

 

Up | Down | Top | Bottom
© Copyright , PDCI Market Access